Trader Loracle increased their HYPE short position by 200,000 tokens, bringing the total size to $68.1 million.
BlockBeats News, May 19th, according to Hyperinsight monitoring, due to the continuous strength of HYPE, this morning it stood above $48. Hyperliquid's well-known trader "Loracle" continuously increased holdings to flatten the HYPE short position, accumulating approximately 200,000 tokens (valued at around $9.4 million).
Currently, using 5x leverage, Loracle is short 1.443 million HYPE tokens, valued at around $68.1 million. The average price has increased from $41.8 to $42.55, with an unrealized loss of $6.76 million (-47%).
In addition, the largest long position holder, who the market once suspected to be the "HYPE listing insider" whale, is still holding a long position on HYPE. They are now going long with 5x leverage on 1.38 million tokens, valued at around $65.3 million, with an average price of $38.67 and an unrealized gain of $11.9 million.
Addresses: 0x8def9f50456c6c4e37fa5d3d57f108ed23992dae
Address: 0x082e843a431aef031264dc232693dd710aedca88
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Jefferies raises Tesla's target price to $400
Goldman Sachs (GS.US) stock plunges 22% into bear market, financial report becomes the key to a breakthrough
Goldman Sachs' market value evaporated by several billions, with its share price down more than 22% from the year's high. Despite Q3 revenue exceeding expectations, a 41% drop in M&A activity and a slowdown in IPOs have dampened market sentiment. Analysts project a 12% revenue increase in Q4, but technical indicators suggest there is further downside risk to $783. Rumors about management transitions have also drawn attention.
Delivery soared by 85% but failed to prevent the death cross; Rivian (RIVN.US) dilution risk sparks panic
Despite the R2 model driving an 85% year-on-year increase in deliveries, Rivian's stock price continues to decline due to technical death cross, high short interest, and risks of equity dilution, facing a severe market test.
